Patrick Soon-Shiong is an individual angel investor who leverages his background as a surgeon and pharmaceutical. See sector focus and contact routes.
About Patrick Soon-Shiong
Patrick Soon-Shiong is an individual angel investor who leverages his background as a surgeon and pharmaceutical entrepreneur, having built his wealth by founding and selling two drug companies for approximately $8 billion before expanding into a broad ecosystem under NantWorks. His investment thesis centers on healthcare, drug discovery, and technology, with a focus on using data and genetic information to pioneer treatments for cancer and other diseases. As an angel investor, he typically invests personal money into promising companies in exchange for equity, with his latest known investment occurring in October 2024 in Alyssum Therapeutics, a drug discovery firm. While specific check sizes and lead/follow behavior are not publicly detailed in available records, his portfolio includes nine total investments, suggesting a selective approach to early-stage opportunities. Notable portfolio companies include Alyssum Therapeutics, NantHealth (which he took public), and ImmunityBio, where he serves as Executive Chairman. Soon-Shiong distinguishes himself through a distinctive point of view that integrates medical science with AI and data transport, holding over
Patrick Soon-Shiong at a glance
Role
Angel Investor
Location
Los Angeles, CA, United States
Investor type
Individual/Angel
Focus areas
Dr. Patrick Soon-Shiong is the Founder and serves as Chairman of the Board of Directors & Chief Executive Officer of NantHealth. Dr. Patrick Soon-Shiong serves as Founder & Chairman at NantVentures. Dr. Patrick Soon-Shiong is the Founder and serves as Chairman & Chief Executive Officer at NantWorks. He is also the Founder of Nant Capital and NantBioscience and also serves as its Director. He serves as a Chairman of Altor BioScience. He a physician, surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has over 95 issued patents on groundbreaking advancements spanning myriad fields. Dr. Soon-Shiong performed the world's first encapsulated human islet transplant, the first engineered islet cell transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation's first FDA approved protein nanoparticle albumin-bound delivery technology for the treatment of can
Frequently asked about Patrick Soon-Shiong
What does Patrick Soon-Shiong invest in?
Patrick Soon-Shiong (Los Angeles, CA, United States) — sector focus: Dr. Patrick Soon-Shiong is the Founder and serves as Chairman of the Board of Directors & Chief Executive Officer of NantHealth. Dr. Patrick Soon-Shiong serves….
How do I contact Patrick Soon-Shiong?
Patrick Soon-Shiong's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Patrick Soon-Shiong headquartered?
Patrick Soon-Shiong is based in Los Angeles, CA, United States.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Los Angeles.
